Thyroid Cancer
Thyroid Cancer: Public Health and Genomic Insights - July 8, 2015
American Thyroid Association statement on surgical application of molecular profiling for thyroid nodules: Current impact on perioperative decision making.
Ferris RL et al. Thyroid 2015 Jun 24.
Ferris RL et al. Thyroid 2015 Jun 24.
PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma.
Petrulea MS et al. Cancer Treat. Rev. 2015 Jun 26.
Petrulea MS et al. Cancer Treat. Rev. 2015 Jun 26.
Molecular pathology of hereditary and sporadic medullary thyroid carcinomas.
Chernock RD et al. Am. J. Clin. Pathol. 2015 Jun (6) 768-777
Chernock RD et al. Am. J. Clin. Pathol. 2015 Jun (6) 768-777
The role of microRNAs in thyroid carcinomas.
Forte S et al. Anticancer Res. 2015 Apr (4) 2037-47
Forte S et al. Anticancer Res. 2015 Apr (4) 2037-47
What is thyroid cancer, from the National Cancer Institute
from the National Cancer InstituteRisk factors for thyroid cancer include genetics and family history, from the American Cancer Society
from the American Cancer SocietyFind our which genetic conditions and tests are associated with thyroid cancer, from the NIH Genetic Testing Registry
from the NIH Genetic Testing RegistryFind out which genes have been reported in relation to thyroid cancer, from the HuGE Navigator
from the HuGE NavigatorClinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ et al. Cancer Genet 2015 Jan 30.
Wei WJ et al. Cancer Genet 2015 Jan 30.
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.
Figlioli G et al. Sci Rep 2015 8922
Figlioli G et al. Sci Rep 2015 8922
Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).
Galofré JC et al. Endocrinol Nutr 2015 Apr (4) e37-46
Galofré JC et al. Endocrinol Nutr 2015 Apr (4) e37-46
Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathies.
Agarwal R et al. Discov Med 2015 Feb (103) 101-8
Agarwal R et al. Discov Med 2015 Feb (103) 101-8
Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy.
Schechter RB et al. Cancer Lett. 2015 Apr 10. (2) 269-74
Schechter RB et al. Cancer Lett. 2015 Apr 10. (2) 269-74
CHEK2 mutations and the risk of papillary thyroid cancer.
Siolek M et al. Int. J. Cancer 2015 Jan 12.
Siolek M et al. Int. J. Cancer 2015 Jan 12.
Epigenetic modifications in human thyroid cancer.
Faam B et al. Biomed Rep 2015 Jan (1) 3-8
Faam B et al. Biomed Rep 2015 Jan (1) 3-8
.png)
No hay comentarios:
Publicar un comentario